Request FREE sample PDF
Pharmacy benefit management market
EGG PHOSPHATIDYLCHOLINE MARKET REPORT OVERVIEW
The global egg phosphatidylcholine market size was USD 13 billion in 2019 and will touch USD 20 billion by 2026, exhibiting a CAGR of 5.9% during the forecast period.
The major source of egg phosphatidylcholine is the phospholipid found in varieties of egg yolk, which is of critical importance in the structure and function properties of cellular membranes. Being composed of choline, phosphate, glycerol, and fatty acids make an important constituent part of cellular signalling and movement and translocation of lipids and proteins over cellular membranes. Phosphatidylcholine supports brain functions, especially in the synthesis of neurotransmitters and stimulation of brain activity. It does help in liver health through the facilitation of metabolism in lipids and stimulation of bile production. This, therefore, makes it emulsifiable and has several uses with application in numerous fields including medicine, pharmaceuticals, and cosmetics, nutritive supplement for any potential health effects.
The market for egg phosphatidylcholine is currently growing healthily, and its use as a source of functional food ingredients and dietary supplement ingredients is rising more and more. Rising consumer knowledge regarding consumption of healthy products for preventive health is boosting the market further. Processes are coming up related to the extraction and processing, and recent advancements have enhanced the supply of egg phosphatidylcholine of the desired quality. Phosphatidylcholine exhibits various favourable properties against the formulation of a number of drugs, thus contributing positively to potential applications as drug vehicles with respective nutraceutical formulations. The growth of egg phosphatidylcholine in the cosmetic and personal product industries, in addition, has further given hope to egg phosphatidylcholine market growth. Generally, the market is expected to develop further as more health-conscious consumers come into play. Applications in breakfast food and dietary supplements as work towards adding the market as a source of important nutrients.
COVID-19 Impact: Market Growth Hampered By Pandemic Due to Disruptions in Supply Chains
The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to market’s growth and demand returning to pre-pandemic levels.
The occurrence of a global COVID-19 pandemic has had a negative influence on the egg phosphatidylcholine market. Given that the supply chain was broken, a negative influence on supply and an influence on inflation were observed. Reduced purchasing power of consumers has been depressed and also followed by shift in dietary habits and reduced demand by consumers. There are also concerned that other market expanding opportunities have been jeopardized with restrictions in international trade and transportation of egg phosphatidylcholine. Moreover, issues over long-lasting and extreme impacts of the pandemic are forcing businesses and consumers in general to be cautious with spending and proceeding with extravagance. Added to these, such factors contributed to downturn in market growth and profitability for the manufacturers, suppliers and producers of Egg Phosphatidylcholine.
LATEST TRENDS
"Growing Demand in Solar Energy Sector to Drive Market Growth"
The egg phosphatidylcholine market has seen noted several trends in the recent years. One of the most important trend is increasing awareness regarding the various health benefits of phosphatidylcholine, such as in providing liver health benefits and supporting cognitive functions. Additionally, the rising demand for natural and organic ingredients by health and wellness-conscious consumers in food and dietary supplements is gradually rendering egg phosphatidylcholine usage much preferred since it has natural origins and is bioavailable. Advancement in extraction technologies would make the productivity of egg phosphatidylcholine more consumable and affordable. In addition, R&D activities are going on for the discovery of new uses that can be brought by egg phosphatidylcholine in pharmaceuticals, cosmetics, and nutraceuticals products, which may further help the market to grow in size. Hence, in other words, consumer health awareness toward phosphatidylcholine, augments in preference toward natural ingredient, development in the technical arena, and new dimensions in application would help the market to progress.
EGG PHOSPHATIDYLCHOLINE MARKET SEGMENTATION
By Type
Based on type the global market can be categorized into Choline, Serine, Inositol, Ethanolamine.
- Choline: The metabolic precursor to the synthesis of acetylcholine, which is the primary neurotransmitter responsible for making the receptors of other body parts convey messages when it comes to activities dealing with learning and remembrance.
- Serine: Serine is an important non-essential amino acid working in the regulation of cellular activity. It is used as a precursor for phosphatidylserine synthesis, the synthesis of protein, phospholipid, and nucleotide.
- Inositol: It is chemical precursor of an intracellular signaling molecule, inositol triphosphate (IP3), and of phosphatidylinositol (PI). These molecules find their engagement way to the cell signaling pathways even when used on neurotransmitters and insulin sensitivity.
- Ethanolamine: Ethanolamine can either bypass any amino alcohol-related major components or include them in the phosphatidylethanolamine of cell membranes. They are all important in the structure and functioning of membranes in general, having an accessory to a number of processes like signaling and membrane trafficking.
By Application
Based on application the global market can be categorized into Cosmetics, Pharmaceutical, Dietary Supplements, Others.
- Cosmetics: These phosphatidylcholine derivatives are used in cosmetic formulations as emulsifiers in creams, lotions, and serums, among many other standard excipients, because of their characteristics of stabilizing the formulation, raising the level of texture, and enhancing the delivery of active agents into the skin.
- Pharmaceutical: Egg phosphatidylcholine is a common excipient in overall use in liposomal drug delivery systems in several pharmaceutical formulations. Liposomes are microscopic vesicles made up of lipids, inclusive of phosphatidylcholine, that allow for drug encapsulation within intended targets, furthering bioavailability.
- Dietary Supplements: It is found in dietary supplements not uncommonly, with health claims mostly surrounding improved liver health and cognitive function. The reason this is quite often included within formulations is that it offers assistance with regard to cellular membrane integrity, and it may have some support with regard to fat metabolism and aiding cognitive function.
- Others: Egg phosphatidylcholines can further find application in other sectors like food industries for use as emulsifiers in food products, besides R&D since they form up a broad series of cells culture media or are used in biotechnology and applications in nanoparticles.
DRIVING FACTORS
"Rising Awareness about Health Benefits of Phosphatidylcholine to Boost the Market Growth"
Increased awareness of a plethora of health benefits associated with the intake of egg- and product-derived phosphatidylcholine and the active role being taken by consumers in monitoring their health will give further impetus to the demand for this product and hence its market expansion. Phosphatidylcholine activity leads to a healthy liver, functioning of the brain, and maintenance of cardiovascular health. The demand for egg phosphatidylcholine is further expected to be driven by an increase in awareness among health-conscious consumers regarding the aforementioned health benefits linked with consuming natural ingredients in dietary supplements and functional foods, thereby moving demand for the product as a nutritious and effective source of choline. In addition to that, the major contributing industry could be the pharmaceutical industry. The primary application of phosphatidylcholine is in drug delivery systems, where they are used as an excipient, since they are biocompatible and can diminish toxicity after iodination. The ever-increasing disease burden across the world and persistent development of improved formulations for a number of chronic diseases, in turn, will propell egg phosphatidylcholine market growth.
"Growing Demand in Cosmetics Industry to Expand the Market"
Phosphatidylcholine, being a good emulsifying agent, is being used in cosmetic formulation. Increasing demand by consumers for natural and sustainable ingredients in skin products would yield a progressive fillip for naturally derived emulsifiers and skin conditioners, such as egg phosphatidylcholine. Furthermore, the food and beverage industry is boosting the egg phosphatidylcholine market. Phosphatidylcholine is used towards forming an emulsion and thus used for emulsifying several other food product types, baked products, as well as dairy preparations and sauces for improving texture and ensuring better stability and prolonged shelf life. In addition, considering the increasing demand from consumers who prefer convenient foods alongside the development of functional foods enriched with health-promoting ingredients, egg phosphatidylcholine is expected to face substantial demand within this segment.
RESTRAINING FACTORS
"Regulatory Challenges to Impede Market Growth"
Regulatory scrutiny and compliance are amongst the major barriers in the market for egg phosphatidylcholine. The regulatory standards, imposed by various regulatory agencies on the production, processing, and labelling of phosphatidylcholine products developed from eggs, are extraordinarily rigid. It lays down to see that the product used is safe, efficacious, with proper quality. But such compliance with guidelines can be quite expensive and time-consuming for manufacturers. New or further changes in regulatory requirements or the introduction of entirely new ones will interfere with the market or act as a barrier to single companies or clusters already present in this space.
EGG PHOSPHATIDYLCHOLINE MARKET REGIONAL INSIGHTS
"North America to Dominate in the Market due to Presence of a Large Consumer Base"
The market is segmented into Europe, Latin America, Asia Pacific, North America, and Middle East & Africa.
North America has emerged as the most dominant region in the global egg phosphatidylcholine market share. In combination with well-placed pharmaceutical and nutraceutical industries present in the region, the advanced egg processing facilities are creating a demand for products that are derived from phosphatidylcholine. Growth of market is fuelled by a strong emphasis on research and development, which would increase innovation to use derivatives of phosphatidylcholine. This further diversifies market presence for this region.
KEY INDUSTRY PLAYERS
"Key Industry Players Shaping the Market through Innovation and Market Expansion"
The egg phosphatidylcholine market is significantly influenced by key industry players that play a pivotal role in driving market dynamics and shaping consumer preferences. These key players possess extensive retail networks and online platforms, providing consumers with easy access to a wide variety of wardrobe options. Their strong global presence and brand recognition have contributed to increased consumer trust and loyalty, driving product adoption. Moreover, these industry giants continually invest in research and development, introducing innovative designs, materials, and smart features in Egg phosphatidylcholine, catering to evolving consumer needs and preferences. The collective efforts of these major players significantly impact the competitive landscape and future trajectory of the market.
LIST OF TOP EGG PHOSPHATIDYLCHOLINE COMPANIES
- Nutrasal (U.S.)
- Avanti Polar Lipids (U.S.)
- Lipoid (Germany)
- Natural Factors (Canada)
- Kewpie (Japan)
- NOF (Japan)
- Jena Bioscience (Germany)
INDUSTRIAL DEVELOPMENT
July 2020: Avanti Polar Lipids agreed to be acquired by CordenPharma International. The acquisition of the company will assist CordenPharma International to grow larger with life science product portfolios, pharmaceutical services, as well as cGMP manufacturing c GMP production capabilities for its biotechnology, pharmaceutical, and life science research customers across the globe.
REPORT COVERAGE
The study encompasses a comprehensive SWOT analysis and provides insights into future developments within the market. It examines various factors that contribute to the growth of the market, exploring a wide range of market categories and potential applications that may impact its trajectory in the coming years. The analysis takes into account both current trends and historical turning points, providing a holistic understanding of the market's components and identifying potential areas for growth.
The research report delves into market segmentation, utilizing both qualitative and quantitative research methods to provide a thorough analysis. It also evaluates the impact of financial and strategic perspectives on the market. Furthermore, the report presents national and regional assessments, considering the dominant forces of supply and demand that influence market growth. The competitive landscape is meticulously detailed, including market shares of significant competitors. The report incorporates novel research methodologies and player strategies tailored for the anticipated timeframe. Overall, it offers valuable and comprehensive insights into the market dynamics in a formal and easily understandable manner.
REPORT COVERAGE | DETAILS |
---|---|
Market Size Value In |
US$ 13 Million in 2019 |
Market Size Value By |
US$ 20 Million by 2026 |
Growth Rate |
CAGR of 5.9% from 2019 to 2026 |
Forecast Period |
2022-2026 |
Base Year |
2023 |
Historical Data Available |
Yes |
Regional Scope |
Global |
Segments Covered |
Types & Application |
Frequently Asked Questions
-
What value is the Egg phosphatidylcholine market expected to touch by 2026?
The Egg phosphatidylcholine market is expected to reach USD 20 million by 2026.
-
What CAGR is the Egg phosphatidylcholine market expected to exhibit by 2026?
The Egg phosphatidylcholine market is expected to exhibit a CAGR of 5.9% by 2026.
-
Which are the driving factors of the Egg phosphatidylcholine market?
Increasing consumer awareness regarding health benefits, rising demand for functional foods and dietary supplements, and growing applications in pharmaceuticals and cosmetics industries are some of the driving factors of the Egg phosphatidylcholine market.
-
What are the Egg phosphatidylcholine market segments?
The Egg phosphatidylcholine market segmentation that you should be aware of, which include, based on type the Egg phosphatidylcholine market is classified as Choline, Serine, Inositol, Ethanolamine. Based on application the Egg phosphatidylcholine market is classified as Cosmetics, Pharmaceutical, Dietary Supplements, Others.